Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of niemann–pick.

Slides:



Advertisements
Similar presentations
Expression of the novel gene embryo implantation factor 2 (EMO2) in the mouse uterus at the implantation sites  Zhaogui Sun, Ph.D., Renwei Su, Ph.D.,
Advertisements

Reduced Tumor Necrosis Factor-α and Transforming Growth Factor-β1 Expression in the Lungs of Inbred Mice that Fail to Develop Fibroproliferative Lesions.
Volume 18, Issue 5, Pages (May 2010)
Volume 14, Issue 3, Pages (September 2006)
by Koji Yamamoto, Vivian de Waard, Colleen Fearns, and David J
Human CD133+ bone marrow-derived stem cells promote endometrial proliferation in a murine model of Asherman syndrome  Irene Cervelló, Ph.D., Claudia Gil-Sanchis,
Volume 18, Issue 2, Pages (February 2010)
Volume 6, Issue 4, Pages (April 1997)
Molecular Therapy - Nucleic Acids
Volume 13, Issue 6, Pages (June 2006)
Volume 25, Issue 7, Pages (July 2017)
Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII  Brian A. Karolewski,
Volume 15, Issue 1, Pages (January 2007)
Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy  Che-Hsin Lee, Chao-Liang Wu, Yun-Sheng.
Volume 13, Issue 6, Pages (June 2006)
Volume 25, Issue 3, Pages (March 2017)
Volume 15, Issue 12, Pages (December 2007)
Volume 2, Issue 5, Pages (November 2000)
Volume 20, Issue 5, Pages (May 2012)
Volume 25, Issue 6, Pages (June 2017)
Volume 12, Issue 5, Pages (November 2005)
Volume 28, Issue 4, Pages (October 2015)
Volume 119, Issue 6, Pages (December 2000)
Volume 13, Issue 2, Pages (February 2006)
Volume 18, Issue 9, Pages (September 2010)
Volume 6, Issue 2, Pages (August 2002)
Volume 19, Issue 3, Pages (March 2011)
Expression of the novel gene embryo implantation factor 2 (EMO2) in the mouse uterus at the implantation sites  Zhaogui Sun, Ph.D., Renwei Su, Ph.D.,
Volume 15, Issue 6, Pages (June 2007)
Volume 9, Issue 6, Pages (June 2004)
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
Volume 25, Issue 12, Pages (December 2017)
Volume 19, Issue 10, Pages (October 2011)
Volume 12, Issue 6, Pages (December 2005)
In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis
Volume 13, Issue 2, Pages (February 2006)
Volume 6, Issue 1, Pages (July 2002)
Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice  Mohammad A.
Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain  Cassia N. Cearley, John.
Volume 38, Issue 3, Pages (March 2013)
Volume 12, Issue 5, Pages (November 2005)
Volume 19, Issue 6, Pages (June 2011)
The Effect of Size and Shape of RNA Nanoparticles on Biodistribution
Hematopoietic Dysfunction in a Mouse Model for Fanconi Anemia Group D1
Volume 9, Issue 8, Pages (April 1999)
Morvarid Moayeri, Teresa S. Hawley, Robert G. Hawley  Molecular Therapy 
Lipopolysaccharide Potentiates the Effect of Hepatocyte Growth Factor upon Replication in Lung, Thyroid, Spleen, and Colon in Rats in Vivo  Cuihua Gao,
Volume 18, Issue 8, Pages (August 2010)
Kasey L Jackson, Robert D Dayton, Ronald L Klein 
Volume 24, Issue 1, Pages (January 2016)
Volume 13, Issue 3, Pages (March 2006)
Volume 26, Issue 1, Pages (January 2018)
Volume 3, Issue 3, Pages (March 2001)
Volume 11, Issue 5, Pages (May 2005)
Y. Castier, S. Lehoux, Y. Hu, G. Fonteinos, A. Tedgui, Q. Xu 
Volume 3, Issue 6, Pages (June 2001)
Volume 10, Issue 6, Pages (December 2004)
Volume 9, Issue 3, Pages (March 2004)
Volume 25, Issue 4, Pages (April 2017)
Rachel Bolante-Cervantes, Shunan Li, Amrik Sahota, Jay A
Single-Shot, Multicycle Suicide Gene Therapy by Replication-Competent Retrovirus Vectors Achieves Long-Term Survival Benefit in Experimental Glioma  Chien-Kuo.
Volume 9, Issue 5, Pages (November 1998)
Volume 6, Issue 4, Pages (April 1997)
Loss of Transgene following ex vivo Gene Transfer is Associated with a Dominant Th2 Response: Implications for Cutaneous Gene Therapy  Zhenmei Lu, Soosan.
Volume 18, Issue 5, Pages (May 2010)
Volume 11, Issue 2, Pages (February 2005)
Volume 3, Issue 5, Pages (May 2001)
Volume 23, Issue 6, Pages (June 2015)
Molecular Therapy - Nucleic Acids
Delivery of a Retroviral Vector Expressing Human β-Glucuronidase to the Liver and Spleen Decreases Lysosomal Storage in Mucopolysaccharidosis VII Mice 
Presentation transcript:

Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of niemann–pick disease  Hee-Kyung Jin, Edward H Schuchman  Molecular Therapy  Volume 8, Issue 6, Pages 876-885 (December 2003) DOI: 10.1016/j.ymthe.2003.07.008 Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

FIG. 1 ASM activities in tissues of transplanted ASMKO and control mice. At (A) 16 and (B) 24 weeks postirradiation, ASM activities were measured in several organs. The histograms show comparisons of the mean ASM activities in the transplanted ASMKO animals (open bars) with the activities detected in the same tissues from untreated ASMKO animals (black bars). Cr, cerebrum; Ce, cerebellum; Li, liver; Sp, spleen; Lu, lung; He, heart; Ki, kidney. Data are expressed as means ± SEM (n = 5). Molecular Therapy 2003 8, 876-885DOI: (10.1016/j.ymthe.2003.07.008) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

FIG. 2 Production of anti-human ASM antibodies in transplanted ASMKO mice. Immunoprecipitation experiments were carried out using pure ASM as the antigen and serum from treated ASMKO, ASMKO control (ASMKO-rad), and normal control (Normal-rad) mice (24 weeks postirradiation). ASM activities were then determined in the immunoprecipitates and supernatants. Data are expressed as means ± SEM (n = 4). Open bars show activities in the immunoprecipitates and black bars the supernatants. Molecular Therapy 2003 8, 876-885DOI: (10.1016/j.ymthe.2003.07.008) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

FIG. 3 (A) Survival of ASMKO mice receiving the dual transplants. By 32 weeks postirradiation, all of the ASMKO irradiation control mice (open circles) had died, while seven of nine transplanted ASMKO (closed circles) and all of the normal (triangles) animals survived. The longest surviving transplanted ASMKO animal lived to 48 weeks postirradiation. N = 9 for each group. (B) Rotarod scores for transplanted ASMKO and control mice. Rotarod scores from the same transplanted (closed circles), ASMKO irradiation control (open circles), and normal (triangles) animals were averaged and plotted beginning at 12 weeks postirradiation. Note that all of the ASMKO irradiation control mice died by 32 weeks postirradiation (see A). Molecular Therapy 2003 8, 876-885DOI: (10.1016/j.ymthe.2003.07.008) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

FIG. 4 Histopathology and sphingomyelin levels in the spleen and cerebellum of transplanted ASMKO and irradiation control mice. (A) Hematoxylin–eosin (top) and lysenin (bottom) staining of spleen sections from representative transplanted ASMKO, ASMKO irradiation control (ASMKO-rad), and normal irradiation control (Normal-rad) mice at 16 weeks postirradiation. (B) Purkinje cell immunohistochemistry at 16 and 24 weeks postirradiation. Purkinje cells were visualized using anti-calbindin antibodies (top). Sphingomyelin staining was performed using lysenin (bottom). Representative images are shown. Original magnification ×40. Molecular Therapy 2003 8, 876-885DOI: (10.1016/j.ymthe.2003.07.008) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

FIG. 5 GFAP immunoreactivity in the cerebellum of ASMKO and normal mice at 16 weeks postirradiation. GFAP-positive astrocytes were increased in the ASMKO irradiation control mice (ASMKO-rad) compared to normal irradiation control mice (Normal-rad). GFAP staining was markedly reduced in the transplanted ASMKO mice compared to untreated ASMKO animals and appeared almost normal. Original magnification ×20. Molecular Therapy 2003 8, 876-885DOI: (10.1016/j.ymthe.2003.07.008) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

FIG. 6 Expression of human ASM RNA in the cerebellum of transplanted ASMKO mice. (A) Antisense or (B) sense human-specific ASM probes and (C) an antisense mouse-specific ASM probe were used to detect ASM RNA in cerebellar sections of transplanted ASMKO, ASMKO irradiation control, and normal irradiation control mice by in situ hybridization. Original magnification ×40. Molecular Therapy 2003 8, 876-885DOI: (10.1016/j.ymthe.2003.07.008) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

FIG. 7 The number of Purkinje cells expressing human ASM RNA at 24 weeks postirradiation. (A) Schematic depiction of a mouse brain showing the location of the hippocampal (circle) and cerebellar (square) injection sites. Nos. 1–4 indicate the locations of sagittal sections used for the quantification studies shown in C. Positions 2 and 3 are 300 μm from the cerebellar injection site and positions 1 and 4 are 600 μm. (B) Schematic depicting the depth and relative location of the cerebellar injection site, including the individual lobes. (C) Quantification of the Purkinje cells expressing human ASM was performed as described under Materials and Methods. A–E refer to the individual cerebellar lobes. Positions 1–4 (A) are indicated by diamonds, squares, triangles, and circles, respectively. For each lobe and position, at least five sections were analyzed and a total of 100 Purkinje cells were counted. Data are expressed as means ± SEM. Molecular Therapy 2003 8, 876-885DOI: (10.1016/j.ymthe.2003.07.008) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions